Evaxion A (EVAX) Short term Debt (2021 - 2025)

Evaxion A (EVAX) posted Short term Debt of $190000.0 for Q4 2025, up 3.26% on a QoQ basis from $184000.0 in Q2 2025, and up 19.5% year-over-year from $159000.0 in Q4 2024.

Evaxion A (EVAX) Short term Debt (2021 - 2025) Analysis & Trends

Evaxion A's Short term Debt history runs 5 years deep, the most recent figure standing at $190000.0 for Q4 2025.

  • Quarterly Short term Debt rose 19.5% year-over-year to $190000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $190000.0 (up 19.5% YoY) and the FY2025 annual result came in at $190000.0, up 19.5% from the prior year.
  • Short term Debt was $190000.0 for Q4 2025 at Evaxion A, up from $184000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $190000.0 in Q4 2025 and bottomed at $119000.0 in Q2 2022.
  • A 5-year average of $151545.5 and a median of $158000.0 in 2024 frame the typical range for Short term Debt.
  • Annual changes were most pronounced in 2023 — Short term Debt climbed 27.73% — and 2024, when it changed 0.0%.
  • Evaxion A's Short term Debt stood at $126000.0 in 2021, then advanced by 7.94% to $136000.0 in 2022, then climbed by 16.91% to $159000.0 in 2023, then changed by 0.0% to $159000.0 in 2024, then advanced by 19.5% to $190000.0 in 2025.
  • Business Quant data shows EVAX's Short term Debt at $190000.0 in Q4 2025, $184000.0 in Q2 2025, and $159000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Evaxion A 25.44 Mn 25.44 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 190,000.00
Jun 30, 2025 184,000.00
Dec 31, 2024 159,000.00
Jun 30, 2024 158,000.00
Dec 31, 2023 159,000.00
Jun 30, 2023 152,000.00
Dec 31, 2022 136,000.00
Jun 30, 2022 119,000.00
Mar 31, 2022 125,000.00
Dec 31, 2021 126,000.00
Sep 30, 2021 159,000.00